Related references
Note: Only part of the references are listed.Exploring the Mechanism of Adjuvant Treatment of Glioblastoma Using Temozolomide and Metformin
Shao-Wei Feng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations
Daniel Y. Zhang et al.
CLINICAL CANCER RESEARCH (2020)
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2020)
Blood-Brain Barrier Modulation to Improve Glioma Drug Delivery
Huilong Luo et al.
PHARMACEUTICS (2020)
Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy
Qi Zhan et al.
THERANOSTICS (2020)
Efficient RNA drug delivery using red blood cell extracellular vesicles
Waqas Muhammad Usman et al.
NATURE COMMUNICATIONS (2018)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
